QA: AMICUS THERAPEUTICS INC. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2022_AMICUS_THERAPEUTICS_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001178879, AMICUS THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 596,834,000
1 IntangibleAssetsNetIncludingGoodwill 220,797,000
2 PropertyPlantAndEquipmentNet 42,496,000
3 remainder_Assets 45,013,000
4 LiabilitiesCurrent 145,975,000
5 LiabilitiesNoncurrent 50,164,000
6 remainder_Liabilities 401,632,000
7 CostOfGoodsAndServicesSold 34,466,000
8 SellingGeneralAndAdministrativeExpense 192,710,000
9 ResearchAndDevelopmentExpense 272,049,000
10 remainder_Expenses 54,100,000
11 remainder_Revenues 305,514,000
12 remainder_NetIncome -2,649,000
13 remainder_ComprehensiveNetIncome -3,246,000
  yvar yval
0 Assets 905,140,000
1 Liabilities 597,771,000
2 Expenses 553,325,000
3 Revenues 305,514,000
4 StockholdersEquity 307,369,000
5 NetIncome -250,460,000
6 ComprehensiveNetIncome -252,083,000
7 BaseVar 1,183,822,500
8 EconomicCapitalRatio 0.368

Edgar->Model Mapping

Feature Distribution

Change over Time